Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Head and Neck Cancer

  Free Subscription


5 Ann Thorac Surg
2 BMC Cancer
2 Br J Cancer
4 Br J Oral Maxillofac Surg
1 Cancer
1 Clin Cancer Res
4 Gastrointest Endosc
2 Histopathology
5 J Laryngol Otol
2 Oral Oncol
1 Radiology

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Thorac Surg

  1. JARDINET T, Niekel MC, Ruppert M, Hubens G, et al
    Fluorescence Guided Thoracic Duct Dissection in Robotic En-bloc Esophagectomy.
    Ann Thorac Surg. 2021 Sep 21. pii: S0003-4975(21)01594.
    PubMed         Abstract available

  2. BOLGER JC, Parente DN, Yeung JC
    Esophagectomy in the setting of left sided portal hypertension.
    Ann Thorac Surg. 2021 Aug 30. pii: S0003-4975(21)01530.
    PubMed         Abstract available

  3. YANG TY, Huang PC, Liu YH, Tsai CY, et al
    Puestow's Procedure Performed During Gastric Conduit Harvesting.
    Ann Thorac Surg. 2022;113:e417-e419.
    PubMed         Abstract available

  4. LINDEN PA, Towe CW, Worrell SG, Jiang B, et al
    Drain Amylase: A Simple and Versatile Method of Detecting Esophageal Anastomotic Leaks.
    Ann Thorac Surg. 2022;113:1794-1800.
    PubMed         Abstract available

    The added burden of previous head and neck cancer in patients facing lung cancer.
    Ann Thorac Surg. 2022 May 19. pii: S0003-4975(22)00717.

    BMC Cancer

  6. MANN C, Berlth F, Hadzijusufovic E, Tagkalos E, et al
    Extended lower paratracheal lymph node resection during esophagectomy for cancer - safety and necessity.
    BMC Cancer. 2022;22:579.
    PubMed         Abstract available

  7. CAI Z, Tang B, Chen L, Lei W, et al
    Mast cell marker gene signature in head and neck squamous cell carcinoma.
    BMC Cancer. 2022;22:577.
    PubMed         Abstract available

    Br J Cancer

  8. MAKINO T, Yamasaki M, Tanaka K, Yamashita K, et al
    Multicenter randomised trial of two versus three courses of preoperative cisplatin and fluorouracil plus docetaxel for locally advanced oesophageal squamous cell carcinoma.
    Br J Cancer. 2022;126:1555-1562.
    PubMed         Abstract available

  9. ALMANGUSH A, Jouhi L, Atula T, Haglund C, et al
    Tumour-infiltrating lymphocytes in oropharyngeal cancer: a validation study according to the criteria of the International Immuno-Oncology Biomarker Working Group.
    Br J Cancer. 2022;126:1589-1594.
    PubMed         Abstract available

    Br J Oral Maxillofac Surg

  10. SHOKOUHI B, Cerajewska T
    Radiotherapy and the survival of dental implants: a systematic review.
    Br J Oral Maxillofac Surg. 2021 Sep 16. pii: S0266-4356(21)00336.
    PubMed         Abstract available

  11. WILLCOCKS EJ, Lim YBY, Rogers SN
    Patients' experience and perceived concerns regarding obtaining and taking prescriptions for head and neck osteoradionecrosis.
    Br J Oral Maxillofac Surg. 2022;60:459-464.
    PubMed         Abstract available

  12. HEDAYAT F, Jerry Htwe KK, Vassiliou LV, Kyzas P, et al
    Morbidity related to the lip-split mandibulotomy approach: a systematic and narrative review.
    Br J Oral Maxillofac Surg. 2022;60:430-436.
    PubMed         Abstract available

  13. YAMAGATA K, Fukuzawa S, Uchida F, Terada K, et al
    Does the geriatric nutrition risk index predict the prognosis of patients with oral squamous cell carcinoma?
    Br J Oral Maxillofac Surg. 2022;60:475-481.
    PubMed         Abstract available


  14. KIYOTA N, Tahara M, Robinson B, Schlumberger M, et al
    Impact of baseline tumor burden on overall survival in patients with radioiodine-refractory differentiated thyroid cancer treated with lenvatinib in the SELECT global phase 3 trial.
    Cancer. 2022 Apr 5. doi: 10.1002/cncr.34181.
    PubMed         Abstract available

    Clin Cancer Res

  15. SCHMITD LB, Perez-Pacheco C, Bellile EL, Wu W, et al
    Spatial and Transcriptomic Analysis of Perineural Invasion in Oral Cancer.
    Clin Cancer Res. 2022 May 26. pii: 699248. doi: 10.1158/1078-0432.CCR-21-4543.
    PubMed         Abstract available

    Gastrointest Endosc

  16. THOTA PN, Nasibli J, Kumar P, Sanaka MR, et al
    Prediction of neoplastic progression in Barrett's esophagus using nanoscale nuclear architecture mapping: a pilot study.
    Gastrointest Endosc. 2022;95:1239-1246.
    PubMed         Abstract available

  17. NGUYEN TH, Thrift AP, Ketwaroo GA, Du XL, et al
    External validation of a model determining risk of neoplastic progression of Barrett's esophagus in a cohort of U.S. veterans.
    Gastrointest Endosc. 2022;95:1113-1122.
    PubMed         Abstract available

  18. DEMEESTER S, Smith C, Severson P, Loveitt A, et al
    Multicenter randomized controlled trial comparing forceps biopsy sampling with wide-area transepithelial sampling brush for detecting intestinal metaplasia and dysplasia during routine upper endoscopy.
    Gastrointest Endosc. 2022;95:1101-1110.
    PubMed         Abstract available

  19. CHAN MW, Pouw RE
    Risk-stratification models for Barrett's esophagus: Will we get to the perfect classifier?
    Gastrointest Endosc. 2022;95:1123-1125.


  20. ANGERILLI V, Lonardi S, Farinati F, Savarino E, et al
    Mismatch repair status and gastro-oesophageal dysplasia: need for a dedicated gastrointestinal pathologist?
    Histopathology. 2022;80:1138-1140.

  21. JANUSZEWICZ W, Pilonis ND, Sawas T, Phillips R, et al
    The utility of P53 immunohistochemistry in the diagnosis of Barrett's oesophagus with indefinite for dysplasia.
    Histopathology. 2022;80:1081-1090.
    PubMed         Abstract available


  22. DYCKHOFF G, Warta R, Herold-Mende C, Plinkert PK, et al
    [Larynx preservation up to T4 laryngeal cancer?]
    HNO. 2022 May 24. pii: 10.1007/s00106-022-01180.
    PubMed         Abstract available

    J Laryngol Otol

  23. ABELARDO E, Gravelle R, Scannell M, Shastri P, et al
    Impact of coronavirus disease 2019 on head and neck urgent suspected cancer referral pathways in rural Wales.
    J Laryngol Otol. 2022;136:540-546.
    PubMed         Abstract available

  24. DONALDSON G, McCadden L, Napier S, Tan TJ, et al
    Laryngeal dysplasia: a 10-year review of rates of progression to invasive carcinoma and treatment-specific outcomes in a regional ENT department in Northern Ireland.
    J Laryngol Otol. 2022;136:547-553.
    PubMed         Abstract available

  25. VAN ABEL KM, Sauer AB, Kruthiventi SC, Weingarten TN, et al
    Non-opioid analgesics and post-operative pain following transoral robotic surgery for oropharyngeal cancer.
    J Laryngol Otol. 2022;136:527-534.
    PubMed         Abstract available

  26. SHAKRAWAL N, Chouhan M, Solanki B
    Diagnostic and treatment challenges in neurofibroma concerning the external nose.
    J Laryngol Otol. 2022;136:473-478.
    PubMed         Abstract available

  27. BAHGAT M, Lim KH, Lester S
    Drain-free neck dissection: The use of Artiss(TM) Fibrin Sealant.
    J Laryngol Otol. 2022 May 26:1-19. doi: 10.1017/S0022215122001256.

    Oral Oncol

    Plasma circulating tumor DNA as a molecular marker for oral cancer.
    Oral Oncol. 2022;130:105926.

  29. SELVARAJ J, Yasothkumar D, Vishnu Priya V, Raj AT, et al
    Development and tumorigenic potential of TP53: A therapeutic target for head and neck squamous cell carcinoma.
    Oral Oncol. 2022;130:105922.


  30. CHEN Y, Gao Z, He Y, Mai W, et al
    An Artificial Intelligence Model Based on ACR TI-RADS Characteristics for US Diagnosis of Thyroid Nodules.
    Radiology. 2022;303:613-619.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.